Anti–N-methyl-ᴅ-aspartate receptor encephalitis in India: a case series and review of the literature
NMDARE patients present with protean clinical manifestations and difficult diagnostic and therapeutic challenges, resulting in an unclear prognosis. Early recognition, aggressive immunotherapy, and regular follow-up are key to better outcomes.
Authors
- Anil Kumar Mishra (ORCID: https://orcid.org/0000-0003-2307-4646)
- Rajarshi Chakraborty (ORCID: https://orcid.org/0000-0003-2304-2177)
- Arjun Bal
- Imran Rizvi (ORCID: https://orcid.org/0000-0002-0818-9851)
- Ravi Uniyal (ORCID: https://orcid.org/0000-0002-1142-8323)
- Harish Nigam (ORCID: https://orcid.org/0000-0002-8570-6568)
- Ankit Khetan (ORCID: https://orcid.org/0000-0001-6266-6703)
- Neeraj Kumar (ORCID: https://orcid.org/0000-0003-2903-1639)
- Rajesh Verma (ORCID: https://orcid.org/0000-0002-3897-2695)
Institutions
- King George's Medical University (IN)
Publication Details
- Journal
- encephalitis
- Published
- 2025-10-09
- DOI
- https://doi.org/10.47936/encephalitis.2025.00052
- Primary Topic
- Autoimmune Neurological Disorders and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00